Pindolol

CAS 13523-86-9 2 current records 7 historicalSmall Molecule

Who holds supplier records for Pindolol? 2 organisations hold a current record for Pindolol: an active US FDA Type II Drug Master File or a CEP. A further 7 organisations have only historical (inactive) DMF filings. 1 of them holds a valid EU Certificate of Suitability. Recorded organisation countries for current records: France (1) and India (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Pindolol: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/pindolol

Reading the evidence

  • 2 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 2 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (2)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Pindolol. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • PCAS
    Active DMF 7188 · latest filing Oct 1987
    FranceCEP Company GMP cert on record
  • CENTAUR PHARMACEUTICALS PVT LTD
    Active DMF 31622 · latest filing Apr 2017
    India Company GMP cert on record
Need Pindolol sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (1)

Certificates of Suitability on the EDQM register for Pindolol, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

HolderCountryCertificateIssuedEU GMP at holder's address
PCAS EcullyFR
R1-CEP 1999-195 - Rev 05
Pindolol
Aug 2022—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (7)

Organisations whose Type II DMFs for Pindolol are no longer active. These show a past filing, not current supply.

Show all 7 historical records
  • Japan · Inactive DMF 15963 · filed Apr 2002
  • DAISO CO LTD
    Inactive DMF 8585 · filed May 1990
  • Italy · Inactive DMF 8547 · filed Apr 1990
  • Daito
    United Kingdom · Inactive DMF 7872 · filed Jan 1989
  • Japan · Inactive DMF 7794 · filed Nov 1988
  • INDUSTRIE CHIMICHE FARMACEUTICHE ITALIANE SPA
    Inactive DMF 6661 · filed Nov 1986
  • ELAN CORP PLC
    Inactive DMF 6313 · filed Mar 1986

Overview

Pindolol is a non-selective beta-blocker used in the treatment of hypertension. It possesses intrinsic sympathomimetic activity which makes it unique among beta-blockers.

Chemical identity

IUPAC name
1-(1H-indol-4-yloxy)-3-(propan-2-ylamino)propan-2-ol
Canonical SMILES
CC(C)NCC(COC1=CC=CC2=C1C=CN2)O
InChIKey
JZQKKSLKJUAGIC-UHFFFAOYSA-N
Synonyms
Visken API, (±)-lb-46, (±)-pindolol, (rs)-pindolol, apo-pindol, betapindol, blocklin-l, calvisken, carvisken, decreten, dl-lb-46, dl-pindolol

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
beta-Adrenergic Blocker
Mechanism of action
Adrenergic beta-Antagonists

Therapeutic areas

CardiovascularAntihypertensiveBeta-blocker

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Pindolol?

2 organisations hold an active US FDA Type II Drug Master File or a CEP for Pindolol: PCAS (France) and CENTAUR PHARMACEUTICALS PVT LTD (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Pindolol Drug Master Files are active?

PCAS (DMF 7188) and CENTAUR PHARMACEUTICALS PVT LTD (DMF 31622). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Pindolol records mean?

7 organisations have only inactive Type II DMFs for Pindolol. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Pindolol have a European Certificate of Suitability?

Yes. 1 organisation holds a valid CEP for Pindolol on the EDQM register, including PCAS Ecully (FR). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Pindolol supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Pindolol?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.